Antibodies Incorporated is the commercial partner for the NIH-funded NeuroMab initiative. NeuroMab was founded in 2005 to develop highly-validated antibodies for the Neuroscience research community. Since then, our catalog has grown to nearly 500 antibodies against critical neuroscience targets and nearly half of these antibodies have been knockout-validated on mouse brain. Antibodies Incorporated has over 50 years of experience providing antibody development and contract manufacturing services. Our contract manufacturing group is a trusted partner for some of the largest life science companies in the world while our Antibody Services group serves pharmaceutical, diagnostics, and academic clients alike.